HAVCR1 and diabetes mellitus: Therefore, as demonstrated in clinical studies, patients with higher levels of KIM-1 (compared to those with lower levels) experience longitudinal function decline and disease progression as demonstrated in CKD patients with and without diabetes mellitus [13, 17, 20, 34, 47, 48].